Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions

August 26, 2010 By Bio-Medicine.Org

IRVINE, Calif., Aug. 26 /PRNewswire-FirstCall/ — Endologix,
Inc. (Nasdaq:  ELGX), developer of minimally invasive
treatments for aortic disorders, announced today that it received
CE Mark approval to market its expanded offering of Powerlink®
stent graft products and PowerFit™ Aortic Extensions in the
European Union.  The Company expects to launch the products in
a limited market release in Europe during the fourth quarter of
2010, followed by a full product launch in 2011.  Endologix
recently received U.S. Food and Drug Administration (FDA) approval
for these new products and they are currently in a limited market
release in the U.S., with a full market release in the U.S. planned
for the fourth quarter of 2010.

John McDermott, President and Chief Executive Officer of
Endologix, said, “We are excited to begin rolling out our expanded
product portfolio following its limited market release in the
United States during the third quarter.  We have received
extremely positive feedback from U.S. physicians on the new sizes
and PowerFit, which gives us confidence that these new devices will
be well received in the European market.  The new sizes of
Powerlink stent grafts are allowing physicians to treat a wider
group of patients, including those with short iliac arteries.
 Physicians are also benefitting from the improved visibility,
conformability and sealing achieved with the PowerFit Aortic
Extensions.  All together, we now have a comprehensive AAA
product offering that will allow us to gain additional market share
in the U.S. and Europe as physicians are able to utilize anatomical
fixation for more of their AAA patients.”

The CE Mark approval covers 31 new sizes of Powerlink main body
bifurcated, proximal extension, and limb extension stent grafts
that increase the system’s addressable patient population by 5% to
10%. It also covers PowerFit Aortic Extensions, which are available
in a range of sizes indica

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech